From 1973 through June 1993, 25 patients underwent pulmonary resection for pulmonary metastases from carcinoma or sarcoma a our institution. There were 11 carcinomas and 14 sarcomas. 24 patients(96% complete) could follow-up and the median
follow-up
time was 20 months with a range of 4 months to 271 months and total follow-up period was 1105 months-patients. In our patients, actuarial 5-year survival rate was 49%, mean survival time was 66.6d*12.6 months and median survival time was 84
months.
Patients with sarcoma, more than 24months of the tumor-free interval, postoperative adjuvant therapy had a better survival than did those with carcinoma, less than 24 months of the tumor-free interval, no postoperative adjuvant therapy. But there
were
no statistical differences between two groups(P>0.05). This results recommend more agressive surgical treatment for pulmonary metastases. (Korean J Thoracic Cardiovas Surg 1994; 27:281-6)
|